Biotechnology major Biocon on Thursday said its subsidiary Biocon Biologics got capital injection of ₹555 crore from Abu Dhabi-based ADQ.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in